7 completed. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 7 |
Follow Hypercalcemia: new trials by email Literature Review of Hypercalcemia trials Research Report on Hypercalcemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy Parathyroid Eye (PTeye) - Parathyroid Diseases, Parathyroid Dysfunction | Not applicable | Completed | University of California, San Francisco | 79 | 2022-01-10 | 2025-12-15 |
| Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy PTeye, Standard of Care - Parathyroid Adenoma, Parathyroid Neoplasms | Not applicable | Completed | University of Michigan | 160 | 2021-12-01 | 2025-08-27 |
| Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy NIRAF Detection Technology - Parathyroid Adenoma, Parathyroid Neoplasms | Not applicable | Completed | Vanderbilt-Ingram Cancer Center | 160 | 2020-03-13 | 2024-05-13 |
| Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients high calcium dialysate - Kidney Disease, Hypercalcemia | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 2007-06-01 | 2018-10-17 | |
| Vitamin D Supplementation in Older Women Vitamin D3, Calcium Citrate (Citracal) - Osteoporosis, Aging | Not applicable | Completed | Creighton University | 273 | 2007-04-01 | 2016-03-14 |
| Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects Oral peptones load - Hyperparathyroidism, Hypercalcemia | Not applicable | Completed | University of Eastern Piedmont | 60 | 2004-07-01 | 2010-01-05 |
| Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community Zoledronic acid (Zometa) - Cancer, Hypercalcemia | Not applicable | Completed | Alberta Health services | 11 | 2004-01-01 | 2011-11-21 |
Hyperparathyroidism, Primary (3) · Parathyroid Neoplasms (3) · Hyperparathyroidism (2) · Adenoma (1) · Endocrine Gland Neoplasms (1) · Hypercalciuria (1) · Kidney Diseases (1) · Neoplasms (1) · Neoplasms, Glandular and Epithelial (1) · Osteoporosis (1) · Pain (1) · Parathyroid Diseases (1) · Renal Insufficiency, Chronic (1) · Vascular Calcification (1)
Calcium Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Water-Electrolyte Imbalance (7) · Endocrine System Diseases (4) · Head and Neck Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Parathyroid Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Endocrine Gland Neoplasms (2) · Hyperparathyroidism (2) · Signs and Symptoms (2) · Avitaminosis (1) · Bone Diseases (1)
Calcium Citrate (1) · Cholecalciferol (1) · Standard of Care (1) · Zoledronic Acid (1)
Alberta Health services (1) · Creighton University (1) · Universitaire Ziekenhuizen KU Leuven (1) · University of California, San Francisco (1) · University of Eastern Piedmont (1) · University of Michigan (1) · Vanderbilt-Ingram Cancer Center (1)
United States (4) · Belgium (1) · Canada (1) · Italy (1)
Carmen C Solorzano, MD, FACS (1) · J C Gallagher, MD (1) · Jose Pereira, MD (1) · Paul Gauger (1) · Quan-Yang Duh, MD, FACS (1)
PMID 40668552, PMID 22431675, PMID 23386641, PMID 24166866, PMID 24937025, PMID 30137647, PMID 31215092
R01CA212147 (3), R01AG028168 (1)